Data / Form D filings / StemBioSys Inc.
StemBioSys Inc.: Form D filings
StemBioSys Inc., a biotechnology company in San Antonio, TX, filed 8 Form D notices with the SEC between 2013 and 2020. The latest, on December 30, 2020, reports an offering of $1.5 million with nothing sold yet.
Find out what StemBioSys Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3463 MAGIC DRIVE, SUITE 110, San Antonio, TX, 78229
- Phone
- (210) 877-9323
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1568861
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 30, 2020 | New notice | $1,541,697 | $0 | $1,541,697 | 0 | Yet to occur | sec.gov |
| Jan 9, 2020 | New notice | $500,000 | $0 | $500,000 | 0 | Yet to occur | sec.gov |
| Jun 19, 2019 | New notice | $3,000,000 | $1,397,565 | $1,602,435 | 32 | May 3, 2019 | sec.gov |
| May 15, 2018 | Amendment | $4,262,000 | $4,060,000 | $202,000 | 47 | Apr 14, 2016 | sec.gov |
| Dec 5, 2016 | Amendment | $5,662,000 | $2,662,000 | $3,000,000 | 17 | Apr 14, 2016 | sec.gov |
| Apr 20, 2016 | New notice | $6,000,000 | $0 | $6,000,000 | 0 | Yet to occur | sec.gov |
| Jul 23, 2013 | Amendment | $8,000,000 | $2,377,802 | $5,622,198 | 22 | Jan 31, 2013 | sec.gov |
| Feb 12, 2013 | New notice | $3,500,000 | $2,000,000 | $1,500,000 | 18 | Jan 31, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ian W Clements | Director | |
| Steven W Davis | Director | |
| Mark Horsey | Executive Officer | |
| Becky Cap | Director | |
| Xiao-Dong W Chen | Director | |
| Robert Hutchens | Executive Officer, Director | |
| Robert Langer | Director | |
| John W Feik | Director | |
| Catherine W Burzik | Director | |
| Jean W Cheever | Director | |
| Paul W Castella | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Dec 28, 2020 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what StemBioSys Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.